Joseph Hargett

Joseph Hargett

InvestorPlace Contributor

About Joseph Hargett

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street Journal, The New York Times, Money Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Take the Long View on Canopy Growth’s Potential

By Joseph Hargett, InvestorPlace Contributor

Canopy Growth is mellowing out after Constellation's $4 billion buy-in. But cannabis stocks are still volatile, so here are two ways to trade CGC stock.

Friday’s Vital Data: Apple, Amazon and Advanced Micro Devices

By Joseph Hargett, InvestorPlace Contributor

AAPL and AMZN options rallied on bullish analyst activity. On the other hand AMD was downgraded at Northland.

Under Armour Stock Is Sprinting Higher — Trade the Breakout

By Joseph Hargett, InvestorPlace Contributor

Under Armour stock is sprinting higher on rising consumer demand and an improving economy. It's time to bet bullish on UAA ahead of earnings.

Thursday’s Vital Data: Square, Netflix and Fortive

By Joseph Hargett, InvestorPlace Contributor

SQ call options rose after a price target hike. NFLX rallied on an industry subscriptions report. FTV was flooded amid its unit sale to Altra.

Earnings Preview: Playing the Long Game with Constellation Brands Stock

By Joseph Hargett, InvestorPlace Contributor

Laying out $4 billion for Canopy Growth (CGC) could hurt Constellation Brands short-term earnings outlook. But with a $200 billion global market on the line, investors should buy the dip in STZ stock.

Load More